Xponance’s Acceleron Pharma XLRN Stock Holding History

Xponance’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,960	Closed	-$1.03M	–	1206
2021 Q3	$1.03M	Sell	5,960 -97	-2%	-$12.7K	0.02%	543
2021 Q2	$760K	Buy	6,057 +1,031	+21%	+$130K	0.01%	720
2021 Q1	$682K	Sell	5,026 -63	-1%	-$8.14K	0.01%	632
2020 Q4	$651K	Buy	5,089 +124	+2%	+$14.5K	0.01%	627
2020 Q3	$559K	Buy	4,965 +508	+11%	+$50.6K	0.01%	597
2020 Q2	$425K	Buy	+4,457	New	+$430K	0.01%	677

Xponance's XLRN Position: Q4 2021 in Review

Xponance sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 5,960 shares — an estimated $1.03M sold.

Xponance first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $1.03M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Xponance reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Xponance sold 5,960 Acceleron Pharma shares in Q4 2021, an estimated $1.03M.
Xponance first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
Xponance's Acceleron Pharma position peaked at $1.03M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Xponance's 13F filing for Q4 2021, filed 31 Jan 2022.